India Diabetes Care Market to Grow with a CAGR of 6.18% through 2030

Rising Prevalence of Diabetes and Technological Advancements in Diabetes Management is expected to drive the India Diabetes Care Market growth in the forecast period, 2026-2030

According to TechSci Research report, “India Diabetes Care Market – By Region, Competition, Forecast & Opportunities, 2030F”, the India Diabetes Care Market stood at USD 15.01 Billion in 2024 and is anticipated to grow with a CAGR of 6.18% in the forecast period, 2026-2030.

The Indian government has introduced several national health initiatives to combat diabetes, notably the National Program for Prevention and Control of Diabetes, Cardiovascular Diseases, and Stroke (NPDCS). These initiatives prioritize awareness, early detection, and effective management of diabetes, thereby enhancing public health infrastructure. By promoting screenings and preventive care, government support not only improves health outcomes but also stimulates demand for diabetes management products. There is a notable increase in public awareness regarding diabetes and its associated risks, driven by educational campaigns from healthcare organizations and NGOs. These initiatives emphasize the significance of regular screenings and effective management strategies, leading individuals to actively seek diabetes-related products and services. Consequently, this heightened awareness fosters a proactive approach to health among the population.

Rapid urbanization in India is significantly contributing to lifestyle changes that increase the prevalence of diabetes. Urban residents often adopt sedentary lifestyles and high-calorie diets, amplifying their risk. This shift creates a burgeoning market for diabetes management solutions, including dietary products, exercise programs, and health monitoring devices tailored specifically for urban populations.

As disposable income rises among the middle and upper classes in India, consumers are increasingly willing to invest in health and wellness. This economic empowerment enables individuals to access quality healthcare products and services, including advanced diabetes management technologies that may have previously been deemed unaffordable. The inclination to spend on preventive healthcare and chronic disease management plays a crucial role in driving market growth. The diabetes care market is also witnessing a surge in collaboration among pharmaceutical companies, medical device manufacturers, and healthcare providers. These partnerships facilitate the development of comprehensive care solutions that integrate medication, monitoring, and lifestyle management. Such collaborative efforts not only enhance patient outcomes but also expand market reach, further propelling overall market growth.

Also, there is a growing emphasis on preventive healthcare, which is reshaping the diabetes care landscape. Both healthcare providers and patients are increasingly recognizing the importance of early detection and proactive diabetes management. This trend is resulting in heightened investments in screening programs and health awareness campaigns, which in turn stimulates demand for diabetes care products and services.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Diabetes Care Market”

The India Diabetes Care Market is segmented into product type, diabetes type, end user, regional distribution, and company.

Based on its diabetes type, the Type 2 Diabetes segment has emerged as the predominant market leader, The significant increase in lifestyle-related risk factors, such as obesity, sedentary behavior, and unhealthy dietary habits, has contributed to the rising incidence of Type 2 Diabetes in urban and rural populations. The increasing prevalence of Type 2 Diabetes is driven by genetic predisposition and lifestyle factors. As urbanization continues to rise, more individuals adopt diets high in carbohydrates and sugars, leading to a surge in obesity rates, which is a key risk factor for Type 2 Diabetes. Growing awareness regarding diabetes management and the importance of regular monitoring has led to an increased demand for treatment options, including oral medications, insulin, and lifestyle modification programs. The development and availability of new antidiabetic medications, including GLP-1 receptor agonists and SGLT2 inhibitors, have expanded treatment options for Type 2 Diabetes. This has driven market growth as healthcare providers can tailor therapies to individual patient needs.

Major companies operating in India Diabetes Care Market are:

• Sanofi
• Novo Nordisk India Private Limited
• USV Private Limited
• Novartis AG
• Merck KGaA
• Becton Dickinson and Company
• F. Hoffmann-La Roche Ltd
• Health Arx Technologies Pvt. Ltd (BeatO)
• Sushant Kumar Ventures Pvt. Ltd. (Genefitletics-Your biology decoded)

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The India Diabetes Care Market is poised for substantial growth, driven by rising diabetes prevalence, increasing awareness of disease management, and technological advancements in treatment options. With Type 2 Diabetes emerging as the dominant segment due to lifestyle changes and urbanization, there is a critical need for comprehensive solutions that encompass both medical and lifestyle interventions. Additionally, the focus on preventive healthcare and government initiatives further supports market expansion. As stakeholders—including healthcare providers, pharmaceutical companies, and medical device manufacturers—collaborate to enhance accessibility and affordability, the India Diabetes Care Market presents significant opportunities for innovation and investment, ultimately aiming to improve health outcomes for millions of individuals affected by diabetes across the country.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“India Diabetes Care Market, By Product Type (Diabetes Care Devices, Diabetes Care Drugs), By Diabetes Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Home Care Settings, Hospitals, Clinics), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated the future growth potential of India Diabetes Care Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Diabetes Care Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]